| 000 | 01031 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517164234.0 | ||
| 264 | 0 | _c20180529 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1473-6500 | ||
| 024 | 7 |
_a10.1097/ACO.0000000000000497 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClarke, Collin F M | |
| 245 | 0 | 0 |
_aNeuraxial drug delivery for the management of cancer pain: cost, updates, and society guidelines. _h[electronic resource] |
| 260 |
_bCurrent opinion in anaesthesiology _cOct 2017 |
||
| 300 |
_a593-597 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCancer Pain _xdrug therapy |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aomega-Conotoxins _xadministration & dosage |
| 773 | 0 |
_tCurrent opinion in anaesthesiology _gvol. 30 _gno. 5 _gp. 593-597 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/ACO.0000000000000497 _zAvailable from publisher's website |
| 999 |
_c27391000 _d27391000 |
||